When you take a look at regional life science companies and their positioning strategies, they may be missing the fundamentals, sometimes by miles. If they were to refocus on the altruistic baby-boomer, some very positive payoffs could ensue. Strength of patent position and the analysis of whether all aspects of IP are being marketed, including non-exclusive and exclusive licensing of secondary and tertiary product candidates. Analysis and review of the company's product pipeline with the intestinal fortitude to kill a project if it's not going to create value for the company. Selection of product candidates that are in sync with the market they will be sold.
Biotech companies are in the business of developing products whose underlying technology is complex.
It occurs to us that it will not be sufficient for regional companies to merely ride the momentum wave. It requires companies to think of themselves not as regional players but as sector players who need to market their science as much as their product applications before the investors show up at the company's front door, curiosity intact, money in hand. Home Copyright 1996-2001 Info. All rights reserved. Privacy Policy .